Table 2.
Baseline inflammatory and immune profile of patients with colorectal cancer divided by survival and non-survival patients.
| Variables | Survival | Non-survival | p value |
|---|---|---|---|
| N=252 | N=193 | ||
| White blood cells, 10³/µL | 7.29 (2.44) | 8.69 (3.59) | <0.001*** |
| Neutrophils, 10³/µL | 4.85 (2.17) | 6.13 (3.38) | <0.001*** |
| Monocytes, 10³/µL | 0.55 (0.50) | 0.63 (0.32) | 0.038* |
| Lymphocytes, 10³/µL | 1.68 (0.54) | 1.64 (0.63) | 0.502 |
| Platelets, 10³/µL | 282 (108) | 314 (118) | 0.003** |
| NER, | 32.4 (21.7) | 38.8 (28.7) | 0.011* |
| NLR, | 3.22 (2.02) | 4.48 (3.69) | <0.001*** |
| NMR, | 10.7 (9.88) | 10.5 (5.18) | 0.726 |
| NPR, | 0.02 (0.01) | 0.02 (0.01) | 0.021* |
| NWR, | 0.65 (0.09) | 0.68 (0.11) | 0.004** |
| NBR, | 99.9 (67.0) | 134 (156) | 0.006** |
| PLR, | 184 (92.0) | 221 (123) | <0.001*** |
| LMR, | 3.89 (3.23) | 3.11 (1.79) | 0.001** |
| hsCRP, mg/dL | 53.9 (68.1) | 73.1 (91.0) | 0.213 |
| Albumin, mg/dL | 3.43 (0.56) | 3.12 (0.56) | 0.007** |
Data are represented as mean (SD) or n (%). Groups were divided according to survival outcomes after 5-years of follow-up. Asterisk indicates significant difference between groups according to the Mann Whitney test and Chi squared test was used for variables expressed as percentage (***p<0.001, **p<0.01, *p<0.05). hsCRP, High-sensitive C reactive protein; NBR, Neutrophil-to-basophil Ratio; NER, Neutrophil-to-eosinophil Ratio; NERR, Neutrophil-to-erythrocyte Ratio; NHR, Neutrophil-to-HDL Ratio; NMR, Neutrophil-to-monocyte ratio; NLR, Neutrophil-to-lymphocyte ratio; NPR, Neutrophil-to- platelet ratio; LDL, light density lipoprotein.